548 related articles for article (PubMed ID: 26060300)
1. Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria.
Yosef I; Manor M; Kiro R; Qimron U
Proc Natl Acad Sci U S A; 2015 Jun; 112(23):7267-72. PubMed ID: 26060300
[TBL] [Abstract][Full Text] [Related]
2. Phage-delivered sensitisation with subsequent antibiotic treatment reveals sustained effect against antimicrobial resistant bacteria.
Liu H; Li H; Liang Y; Du X; Yang C; Yang L; Xie J; Zhao R; Tong Y; Qiu S; Song H
Theranostics; 2020; 10(14):6310-6321. PubMed ID: 32483454
[TBL] [Abstract][Full Text] [Related]
3. Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting.
Goldberg GW; Jiang W; Bikard D; Marraffini LA
Nature; 2014 Oct; 514(7524):633-7. PubMed ID: 25174707
[TBL] [Abstract][Full Text] [Related]
4. Reversing bacterial resistance to antibiotics by phage-mediated delivery of dominant sensitive genes.
Edgar R; Friedman N; Molshanski-Mor S; Qimron U
Appl Environ Microbiol; 2012 Feb; 78(3):744-51. PubMed ID: 22113912
[TBL] [Abstract][Full Text] [Related]
5. Counteracting selection for antibiotic-resistant bacteria.
Yosef I; Manor M; Qimron U
Bacteriophage; 2016; 6(1):e1096996. PubMed ID: 27144084
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Cas immunity against phages: its effects on the evolution and survival of bacterial pathogens.
Marraffini LA
PLoS Pathog; 2013; 9(12):e1003765. PubMed ID: 24348245
[No Abstract] [Full Text] [Related]
7. Holding a grudge: persisting anti-phage CRISPR immunity in multiple human gut microbiomes.
Mick E; Stern A; Sorek R
RNA Biol; 2013 May; 10(5):900-6. PubMed ID: 23439321
[TBL] [Abstract][Full Text] [Related]
8. Keeping crispr in check: diverse mechanisms of phage-encoded anti-crisprs.
Trasanidou D; Gerós AS; Mohanraju P; Nieuwenweg AC; Nobrega FL; Staals RHJ
FEMS Microbiol Lett; 2019 May; 366(9):. PubMed ID: 31077304
[TBL] [Abstract][Full Text] [Related]
9. Anti-CRISPR: discovery, mechanism and function.
Pawluk A; Davidson AR; Maxwell KL
Nat Rev Microbiol; 2018 Jan; 16(1):12-17. PubMed ID: 29062071
[TBL] [Abstract][Full Text] [Related]
10. Anti-CRISPR proteins: Counterattack of phages on bacterial defense (CRISPR/Cas) system.
Chaudhary K; Chattopadhyay A; Pratap D
J Cell Physiol; 2018 Jan; 233(1):57-59. PubMed ID: 28247934
[TBL] [Abstract][Full Text] [Related]
11. Revenge of the phages: defeating bacterial defences.
Samson JE; Magadán AH; Sabri M; Moineau S
Nat Rev Microbiol; 2013 Oct; 11(10):675-87. PubMed ID: 23979432
[TBL] [Abstract][Full Text] [Related]
12. Targeting of temperate phages drives loss of type I CRISPR-Cas systems.
Rollie C; Chevallereau A; Watson BNJ; Chyou TY; Fradet O; McLeod I; Fineran PC; Brown CM; Gandon S; Westra ER
Nature; 2020 Feb; 578(7793):149-153. PubMed ID: 31969710
[TBL] [Abstract][Full Text] [Related]
13. Phage Therapy: Going Temperate?
Monteiro R; Pires DP; Costa AR; Azeredo J
Trends Microbiol; 2019 Apr; 27(4):368-378. PubMed ID: 30466900
[TBL] [Abstract][Full Text] [Related]
14. Repeated outbreaks drive the evolution of bacteriophage communication.
Doekes HM; Mulder GA; Hermsen R
Elife; 2021 Jan; 10():. PubMed ID: 33459590
[TBL] [Abstract][Full Text] [Related]
15. The disparate effects of bacteriophages on antibiotic-resistant bacteria.
Torres-Barceló C
Emerg Microbes Infect; 2018 Oct; 7(1):168. PubMed ID: 30302018
[TBL] [Abstract][Full Text] [Related]
16. Suppressing the CRISPR/Cas adaptive immune system in bacterial infections.
Gholizadeh P; Aghazadeh M; Asgharzadeh M; Kafil HS
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2043-2051. PubMed ID: 28601970
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas System: A New Dawn to Combat Antibiotic Resistance.
Rafiq MS; Shabbir MA; Raza A; Irshad S; Asghar A; Maan MK; Gondal MA; Hao H
BioDrugs; 2024 May; 38(3):387-404. PubMed ID: 38605260
[TBL] [Abstract][Full Text] [Related]
18. Conquering CRISPR: how phages overcome bacterial adaptive immunity.
Malone LM; Birkholz N; Fineran PC
Curr Opin Biotechnol; 2021 Apr; 68():30-36. PubMed ID: 33113496
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of CRISPR-mediated microbial immunity.
Gasiunas G; Sinkunas T; Siksnys V
Cell Mol Life Sci; 2014 Feb; 71(3):449-65. PubMed ID: 23959171
[TBL] [Abstract][Full Text] [Related]
20. Exploitation of the Cooperative Behaviors of Anti-CRISPR Phages.
Chevallereau A; Meaden S; Fradet O; Landsberger M; Maestri A; Biswas A; Gandon S; van Houte S; Westra ER
Cell Host Microbe; 2020 Feb; 27(2):189-198.e6. PubMed ID: 31901522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
